2024 | 2024 | 2024 | 2023 | 2023 | 2023 | ||
€’000 | €’000 | €’000 | €’000 | €’000 | €’000 | ||
Exceptional | Exceptional | ||||||
Underlying | items* | Total | Underlying | items* | Total | ||
Accoya wood revenue | |||||||
Tricoya panel revenue | |||||||
Licence revenue | |||||||
Other revenue | |||||||
Total revenue | 3 | ||||||
Cost of sales | ( | ( | ( | ( | |||
Gross profit | |||||||
Other operating costs | 4 | ( | ( | ( | ( | ( | ( |
Operating (loss)/profit | 8 | ( | ( | ( | ( | ( | |
Finance income | 9 | ||||||
Finance expense | 10 | ( | ( | ( | |||
Share of net loss from joint venture | |||||||
accounted for using the equity method | 28 | ( | ( | ( | ( | ||
(Loss)/Profit before taxation | ( | ( | ( | ( | ( | ||
Tax expense | ( | ( | ( | ( | |||
(Loss)/Profit for the year | ( | ( | ( | ( | ( | ||
Items that may be reclassified to profit or loss | |||||||
Gain/(loss) arising on translation of foreign operations | ( | ( | |||||
Gain/(loss) arising on foreign currency | |||||||
cash flow hedges | |||||||
Total other comprehensive (loss)/gain | ( | ( | |||||
Total comprehensive gain/(loss) for the year | ( | ( | ( | ( | ( | ||
Total comprehensive gain/(loss) for the year is attributable to: | |||||||
Owners of Accsys Technologies PLC | ( | ( | ( | ( | ( | ||
Non-controlling interests | ( | ( | ( | ||||
Total comprehensive gain/(loss) for the year | ( | ( | ( | ( | ( | ||
Basic profit/(loss) per ordinary share | 13 | €( | €( | € | €( | ||
Diluted profit/(loss) per ordinary share | 13 | € |
2024 | 2023 | ||
€’000 | €’000 | ||
Non-current assets | |||
Intangible assets | 15 | ||
Investment accounted for using the equity method | 28 | ||
Property, plant and equipment | 16 | ||
Right of use assets | 17 | ||
Financial asset at fair value through profit or loss | 18 | ||
Current assets | |||
Inventories | 21 | ||
Trade and other receivables | 22 | ||
Cash and cash equivalents | 29 | ||
Corporation tax receivable | |||
Current liabilities | |||
Trade and other payables | 24 | ( | ( |
Obligation under lease liabilities | 17 | ( | ( |
Short term borrowings | 29 | ( | |
Corporation tax payable | ( | ( | |
( | ( | ||
Net current assets | |||
Non-current liabilities | |||
Obligation under lease liabilities | 17 | ( | ( |
Other long term borrowings | 29 | ( | ( |
Financial guarantee | 31 | ||
Financial liability at amortised cost | 23 | ( | ( |
( | ( | ||
Net assets | |||
Equity | |||
Share capital | 25 | ||
Share premium account | |||
Other reserves | 26 | ||
Accumulated loss | ( | ( | |
Own shares | ( | ( | |
Foreign currency translation reserve | |||
Capital value attributable to owners of Accsys Technologies PLC | |||
Non-controlling interest in subsidiaries | 27 | ||
Total equity |
Total equity | |||||||||
Foreign | attributable | ||||||||
Share | currency | to equity | Non- | ||||||
capital | Share | Other | Own | translation | Accumulated | shareholders of | Controlling | Total | |
Ordinary | premium | reserves | Shares | reserve | Loss | the company | interests | Equity | |
€000 | €000 | €000 | €000 | €000 | €000 | €000 | €000 | €000 | |
Balance at 31 March 2022 | ( | ( | |||||||
Loss for the year | ( | ( | ( | ( | |||||
Other comprehensive | |||||||||
gain/(loss) for the year | ( | ( | ( | ||||||
Share based payments | |||||||||
Shares issued | ( | ( | |||||||
Premium on shares issued | |||||||||
Share issue costs | ( | ( | ( | ||||||
Acquisition of subsidiary | |||||||||
shares from non-controlling interests | ( | ( | |||||||
Balance at 31 March 2023 | ( | ( | |||||||
Loss for the year | ( | ( | ( | ||||||
Other comprehensive | |||||||||
gain/(loss) for the year | |||||||||
Share based payments | |||||||||
Shares issued | |||||||||
Premium on shares issued | |||||||||
Share issue costs | ( | ( | ( | ||||||
Acquisition of subsidiary | |||||||||
shares from non-controlling interests | |||||||||
Balance at 31 March 2024 | ( | ( |
2024 | 2023 | |
€’000 | €’000 | |
(Loss)/profit before taxation | ( | ( |
Adjustments for: | ||
Amortisation of intangible assets | ||
Depreciation of property, plant and equipment, and right of use assets | ||
Impairment loss | ||
Net finance expenses/(income) | ( | |
Equity-settled share-based payment expenses | ||
Accsys portion of Licence fee received from joint venture | ||
Share of net loss of joint venture | ||
Currency translation losses/(gains) | ( | |
Cash inflows from operating activities before changes in working capital | ||
(Increase)/decrease in trade and other receivables | ( | |
(Increase)/decrease in inventories | ( | |
Increase/(decrease) in trade and other payables | ( | |
Net cash from operating activities before tax | ||
Tax received | ||
Net cash from operating activities | ||
Cash flows from investing activities | ||
Investment in property, plant and equipment | ( | ( |
Foreign exchange deal settlement related to hedging of Hull Capex | ( | |
Investment in intangible assets | ( | ( |
Investment in joint venture | ( | ( |
Net cash (used in) investing activities | ( | ( |
Cash flows from financing activities | ||
Proceeds from loans | ||
Other finance costs | ( | ( |
Interest Paid | ( | ( |
Repayment of lease liabilities | ( | ( |
Repayment of loans/rolled up interest | ( | |
Proceeds from issue of share capital | ||
Share issue costs | ( | ( |
Net cash from financing activities | ||
Net decrease in cash and cash equivalents | ( | |
Effect of exchange rate changes on cash and cash equivalents | ||
Opening cash and cash equivalents | ||
Closing cash and cash equivalents |
Accoya Segment | ||||||
Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
2024 | 2024 | 2024 | 2023 | 2023 | 2023 | |
Exceptional | Exceptional | |||||
Underlying | items | TOTAL | Underlying | items | TOTAL | |
€’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Accoya wood revenue | 123,139 | – | 123,139 | 143,494 | – | 143,494 |
Licence revenue | – | – | – | 300 | – | 300 |
Other revenue | 8,770 | – | 8,770 | 16,773 | – | 16,773 |
Total Revenue | 131,909 | – | 131,909 | 160,567 | – | 160,567 |
Cost of sales | (91,393) | – | (91,393) | (105,608) | – | (105,608) |
Gross profit | 40,516 | – | 40,516 | 54,959 | – | 54,959 |
Other operating costs | (28,859) | (1,000) | (29,859) | (27,912) | – | (27,912) |
Profit from operations | 11,657 | (1,000) | 10,657 | 27,047 | – | 27,047 |
Profit from operations / EBIT | 11,657 | (1,000) | 10,657 | 27,047 | – | 27,047 |
Depreciation and amortisation | 8,947 | – | 8,947 | 7,695 | – | 7,695 |
EBITDA | 20,604 | (1,000) | 19,604 | 34,742 | – | 34,742 |
Year ended | Year ended | |
31 March | 31 March | |
2024 | 2023 | |
€’000 | €’000 | |
Profit / (loss) from operations / Underlying EBIT | 11,657 | 27,047 |
Accoya USA EBIT | (3,993) | (911) |
Adjusted EBIT | 7,664 | 26,136 |
Year ended | Year ended | |
31 March | 31 March | |
2024 | 2023 | |
€’000 | €’000 | |
Underlying EBITDA | 20,604 | 34,742 |
Accoya USA EBITDA | (3,724) | (700) |
Adjusted EBITDA | 16,880 | 34,042 |
2024 | 2023 | |
€’000 | €’000 | |
Accoya segmental underlying EBITDA | 20,604 | 34,742 |
Accoya underlying Licence revenue | – | (300) |
Accoya segmental underlying EBITDA (excluding. Licence Income) | 20,604 | 34,442 |
Accoya segmental underlying gross profit | 40,516 | 54,959 |
Accoya underlying Licence revenue | – | (300) |
Accoya manufacturing gross profit | 40,516 | 54,659 |
Accoya Manufacturing Margin | 30.7% | 34.1% |
2024 | 2023 | |
Accoya Manufacturing gross profit – €’000 | 40,516 | 54,659 |
Accoya sales volume – m 3 | 56,568 | 63,344 |
Accoya manufacturing gross profit per m 3 | 716 | 863 |
Tricoya Segment | ||||||
Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
2024 | 2024 | 2024 | 2023 | 2023 | 2023 | |
Exceptional | Exceptional | |||||
Underlying | items | TOTAL | Underlying | items | TOTAL | |
€’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Tricoya panel revenue | 4,134 | – | 4,134 | 1,373 | – | 1,373 |
Licence revenue | 77 | – | 77 | 29 | – | 29 |
Other revenue | 50 | – | 50 | 49 | – | 49 |
Total Revenue | 4,261 | – | 4,261 | 1,451 | – | 1,451 |
Cost of sales | (3,894) | – | (3,894) | (1,244) | – | (1,244) |
Gross profit | 367 | – | 367 | 207 | – | 207 |
Other operating costs | (6,961) | (7,200) | (14,161) | (5,823) | (86,000) | (91,823) |
Loss from operations | (6,594) | (7,200) | (13,794) | (5,616) | (86,000) | (91,616) |
Loss from operations | (6,594) | (7,200) | (13,794) | (5,616) | (86,000) | (91,616) |
Depreciation and amortisation | 566 | – | 566 | 527 | – | 527 |
Impairment | – | 7,000 | 7,000 | – | 86,000 | 86,000 |
EBITDA | (6,028) | (200) | (6,228) | (5,089) | – | (5,089) |
Corporate Segment | ||||||
Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
2024 | 2024 | 2024 | 2023 | 2023 | 2023 | |
Exceptional | Exceptional | |||||
Underlying | items | TOTAL | Underlying | items | TOTAL | |
€’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Accoya wood revenue | – | – | – | – | – | – |
Licence revenue | – | – | – | – | – | – |
Other revenue | – | – | – | – | – | – |
Total Revenue | – | – | – | – | – | – |
Cost of sales | – | – | – | – | – | – |
Gross result | – | – | – | – | – | – |
Other operating costs | (4,617) | – | (4,617) | (4,681) | (1,453) | (6,134) |
Loss from operations | (4,617) | – | (4,617) | (4,681) | (1,453) | (6,134) |
Loss from operations | (4,617) | – | (4,617) | (4,681) | (1,453) | (6,134) |
Depreciation and amortisation | – | – | – | – | – | – |
EBITDA | (4,617) | – | (4,617) | (4,681) | (1,453) | (6,134) |
Research & Development Segment | ||||||
Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
2024 | 2024 | 2024 | 2023 | 2023 | 2023 | |
Exceptional | Exceptional | |||||
Underlying | items | TOTAL | Underlying | items | TOTAL | |
€’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Accoya wood revenue | – | – | – | – | – | – |
Licence revenue | – | – | – | – | – | – |
Other revenue | – | – | – | – | – | – |
Total Revenue | – | – | – | – | – | – |
Cost of sales | – | – | – | – | – | – |
Gross result | – | – | – | – | – | – |
Other operating costs | (1,490) | – | (1,490) | (1,458) | – | (1,458) |
Loss from operations | (1,490) | – | (1,490) | (1,458) | – | (1,458) |
Loss from operations | (1,490) | – | (1,490) | (1,458) | – | (1,458) |
Depreciation and amortisation | 66 | – | 66 | 67 | – | 67 |
EBITDA | (1,424) | – | (1,424) | (1,391) | – | (1,391) |
Total | ||||||
Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
2024 | 2024 | 2024 | 2023 | 2023 | 2023 | |
Exceptional | Exceptional | |||||
Underlying | items | TOTAL | Underlying | items | TOTAL | |
€’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Accoya/Tricoya revenue | 127,273 | – | 127,273 | 144,867 | – | 144,867 |
Licence revenue | 77 | – | 77 | 329 | – | 329 |
Other revenue | 8,820 | – | 8,820 | 16,822 | – | 16,822 |
Total Revenue | 136,170 | – | 136,170 | 162,018 | – | 162,018 |
Cost of sales | (95,287) | – | (95,287) | (106,852) | – | (106,852) |
Gross profit | 40,883 | – | 40,883 | 55,166 | – | 55,166 |
Other operating costs | (41,927) | (8,200) | (50,127) | (39,878) | (87,453) | (127,331) |
Profit/ (loss) from operations | (1,044) | (8,200) | (9,244) | 15,288 | (87,453) | (72,165) |
Finance income | 138 | – | 138 | – | – | – |
Finance expense | (4,418) | 530 | (3,888) | (3,224) | 9,350 | 6,126 |
Investment in joint venture | (4,100) | – | (4,100) | (1,036) | – | (1,036) |
Profit/(Loss) before taxation | (9,424) | (7,670) | (17,094) | 11,028 | (78,103) | (67,075) |
Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
2024 | 2024 | 2024 | 2023 | 2023 | 2023 | |
Exceptional | Exceptional | |||||
items | TOTAL | items | TOTAL | |||
€’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Profit / (loss) from operations / EBIT | (1,044) | (8,200) | (9,244) | 15,288 | (87,453) | (72,165) |
Depreciation and amortisation | 9,579 | – | 9,579 | 8,292 | – | 8,292 |
Impairment | – | 7,000 | 7,000 | – | 86,000 | 86,000 |
EBITDA | 8,535 | (1,200) | 7,335 | 23,580 | (1,453) | 22,127 |
Year ended | Year ended | |
31 March | 31 March | |
2024 | 2023 | |
€’000 | €’000 | |
Profit / (loss) from operations / Underlying EBIT | (1,044) | 15,288 |
Accoya USA EBIT | (3,993) | (911) |
Adjusted EBIT | (5,037) | 14,377 |
Year ended | Year ended | |
31 March | 31 March | |
2024 | 2023 | |
€’000 | €’000 | |
Underlying EBITDA | 8,535 | 23,580 |
Accoya USA EBITDA | (3,724) | (700) |
Adjusted EBITDA | 4,811 | 22,880 |
2024 | 2023 | |
Analysis of Revenue by geographical area of customers: | €’000 | €’000 |
UK and Ireland | 46,903 | 55,395 |
Rest of Europe | 47,364 | 63,635 |
Americas | 28,878 | 29,778 |
Rest of World | 13,025 | 13,210 |
136,170 | 162,018 |
Accoya | Tricoya | Corporate | R&D | TOTAL | Accoya | Tricoya | Corporate | R&D | TOTAL | |
2024 | 2024 | 2024 | 2024 | 2024 | 2023 | 2023 | 2023 | 2023 | 2023 | |
€’000 | €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Non-current assets | 118,134 | 19,697 | 1,016 | 96 | 138,943 | 123,705 | 27,047 | 531 | 162 | 151,445 |
Current assets | 43,552 | 3,162 | 18,711 | 5,607 | 71,032 | 52,699 | 3,872 | 13,630 | 4,872 | 75,073 |
Current liabilities | (10,344) | (11,705) | (4,101) | (56) | (26,206) | (23,413) | (4,156) | (14,833) | (56) | (42,458) |
Net current assets/ | ||||||||||
(liabilities) | 33,208 | (8,543) | 14,610 | 5,551 | 44,826 | 29,286 | (284) | (1,203) | 4,816 | 32,615 |
Non-current | ||||||||||
liabilities | (1,979) | (7,803) | (55,137) | (35) | (64,954) | (2,545) | (8,665) | (50,289) | (59) | (61,558) |
Net assets/ | ||||||||||
(liabilities) | 149,363 | 3,351 | (39,511) | 5,612 | 118,815 | 150,446 | 18,098 | (50,961) | 4,919 | 122,502 |
2024 | 2023 | |
€’000 | €’000 | |
UK | 23,129 | 30,485 |
Other countries | 111,583 | 116,729 |
Unallocated – Goodwill | 4,231 | 4,231 |
138,943 | 151,445 |
2024 | 2023 | |
€’000 | €’000 | |
Sales and marketing | 6,044 | 5,219 |
Research and development | 1,490 | 1,458 |
Other operating costs | 11,731 | 10,675 |
Administration costs | 13,083 | 14,234 |
Exceptional Items | 1,200 | 1,453 |
Other operating costs excluding depreciation and amortisation | 33,548 | 33,039 |
Depreciation and amortisation | 9,579 | 8,292 |
Impairment loss – exceptional item | 7,000 | 86,000 |
Total other operating costs | 50,127 | 127,331 |
2024 | 2023 | |
€’000 | €’000 | |
Advisor fees in relation to Tricoya consortium reorganisation | – | (1,453) |
Impairment of the Tricoya segment assets | (7,000) | (86,000) |
Partial net derecogition of NatWest loan | – | 9,353 |
Revaluation / recognition of Valuation Recovery Instrument “VRI” liability | 281 | (1,383) |
Foreign exchange differences on Corporate USD cash held for investment in to USA JV- incl. in Finance expense | 249 | 1,380 |
Restructuring costs | (1,200) | – |
Total exceptional items | (7,670) | (78,103) |
2024 | 2023 | |
€’000 | €’000 | |
Staff costs (including Directors) consist of: | ||
Wages and salaries | 18,508 | 18,584 |
Social security costs | 3,044 | 2,838 |
Other pension costs | 1,357 | 1,573 |
Share based payments | 1,494 | 201 |
24,403 | 23,196 |
2024 | 2023 | |
Sales and marketing, administration, research and engineering | 122 | 142 |
Operating | 114 | 103 |
236 | 245 |
2024 | 2023 | |
€’000 | €’000 | |
Directors’ remuneration consists of: | ||
Directors’ emoluments | 1,450 | 1,170 |
Company contributions to money purchase pension schemes | 52 | 38 |
1,502 | 1,208 |
Salary, bonus | Share based | ||||
and short | payments | 2024 | 2023 | ||
term benefits | Pension | charge | Total | Total | |
€’000 | €’000 | €’000 | €’000 | €’000 | |
Jelena Arsic van Os | 477 | 27 | 171 | 675 | – |
Steven Salo | 401 | 25 | 27 | 453 | – |
Rob Harris | – | – | – | – | 619 |
William Rudge | – | – | – | – | 100 |
878 | 52 | 198 | 1,128 | 719 |
2024 | 2023 | |
€’000 | €’000 | |
This has been arrived at after charging/(crediting): | ||
Staff costs | 24,403 | 23,196 |
Depreciation of property, plant and equipment, and right of use assets | 8,751 | 7,512 |
Impairment | 7,000 | 86,000 |
Amortisation of intangible assets | 828 | 780 |
Operating lease rentals | 40 | 77 |
Foreign exchange losses / (gains) | 108 | (70) |
Research & Development (excluding staff costs) | 700 | 469 |
Fees payable to the Company’s auditors for the audit of the Group’s annual financial statements | 193 | 183 |
Fees payable to the Company’s auditors for other services: | ||
– audit of the Company’s subsidiaries pursuant to legislation | 212 | 205 |
– audit related assurance services | – | – |
Fees payable to Component auditor for audit of subsidiaries: | 190 | 182 |
Total audit and audit related services: | 595 | 570 |
2024 | 2023 | |
€’000 | €’000 | |
Interest receivable on bank and other deposits | 138 | – |
2024 | 2023 | |
€’000 | €’000 | |
Arnhem land and buildings lease finance charge | 159 | 179 |
Interest on loans | 3,536 | 2,500 |
Interest on lease liabilities | 133 | 115 |
Other finance expenses | 590 | 430 |
Total underlying finance expenses | 4,418 | 3,224 |
Exceptional items and other adjustments | ||
Foreign exchange (gain) on Corporate USD cash held for investment in to USA JV | (249) | (1,380) |
Partial derecogition of NatWest loan | – | (9,353) |
Revaluation / recognition of Valuation Recovery Instrument “VRI” | (281) | 1,383 |
Total Finance expense / (income) | 3,888 | (6,126) |
2024 | 2023 | |
€’000 | €’000 | |
(a) Tax recognised in the statement of comprehensive income comprises: | ||
Current tax charge | ||
UK Corporation tax on losses for the year | – | – |
Research and development tax expense in respect of prior year | 121 | – |
Research and development tax (credit) in respect of current year | – | (121) |
121 | (121) | |
Overseas tax at rate of 15% | 8 | 32 |
Overseas tax at rate of 25% | 636 | 2,876 |
Deferred Tax | ||
Utilisation of deferred tax asset | – | – |
Total tax charge reported in the statement of comprehensive income | 765 | 2,787 |
2024 | 2023 | |
€’000 | €’000 | |
(b) The tax charge for the period is higher than the standard rate of corporation tax in the UK | ||
(2024: 25%, 2023: 19%) due to: | ||
Profit/(Loss) before tax | (17,094) | (67,075) |
Expected tax charge at 25% (2023 – 19%) | (4,273) | (12,744) |
Expenses not deductible in determining taxable profit | – | 148 |
Tricoya segment assets impairment | 1,750 | 16,340 |
Tax (income)/losses for which no deferred income tax asset was (utilised)/recognised | 3,159 | (1,654) |
Effects of overseas taxation | 8 | 818 |
Research and development tax charge/ (credit) in respect of prior years | 121 | 3 |
Research and development tax (credit) in respect of current year | – | (124) |
Total tax charge reported in the statement of comprehensive income | 765 | 2,787 |
Deferred tax assets | Deferred tax liabilities | |||
€ ‘000 | 2024 | 2023 | 2024 | 2023 |
At 1 April | 621 | 484 | (621) | (484) |
Credited/ (charged) to the consolidated income statement | (112) | 137 | 112 | (137) |
At 31 March | 509 | 621 | (509) | (621) |
2024 | 2023 | |
€’000 | €’000 | |
Final Dividend €Nil (2023: €Nil) per Ordinary share proposed and paid during year relating to the previous | ||
year’s results | – | – |
2024 | 2023 | |||
Underlying | Total | Underlying | Total | |
Basic earnings per share | ||||
Weighted average number of Ordinary shares in issue (‘000) | 227,911 | 227,911 | 210,693 | 210,693 |
Profit/(Loss) for the year attributable to owners of Accsys Technologies PLC (€’000) | (10,189) | (17,859) | 9,528 | (39,038) |
Basic profit/(loss) per share | € (0.04) | € (0.08) | € 0.05 | € (0.19) |
Diluted earnings per share | ||||
Weighted average number of Ordinary shares in issue (‘000) | – | – | 210,693 | – |
Equity options attributable to BGF (see note 30) | – | – * | 8,449 | – * |
Equity options attributable to convertible loan note issued (see note 29) | – | – | – | – |
Weighted average number of Ordinary shares in issue and potential ordinary shares (‘000) | – | – | 219,142 | – |
Profit/(Loss) for the year attributable to owners of Accsys Technologies PLC (€’000) | – | – | 9,528 | – |
Diluted profit/(loss) per share | – | – * | € 0.04 | – * |
Number of outstanding options | Weighted average remaining | |||
at 31 March | contractual life, in years | |||
Date of grant | 2024 | 2023 | 2024 | 2023 |
19 September 2013 (LTIP) | – | 443,675 | – | 0.5 |
24 June 2016 (LTIP) | 130,099 | 130,099 | 2.3 | 3.3 |
20 June 2017 (LTIP) | 100,651 | 100,651 | 3.3 | 4.3 |
18 June 2018 (LTIP) | 61,407 | 185,840 | 4.3 | 5.3 |
15 July 2020 (LTIP) | – | 850,540 | 6.3 | 7.3 |
23 June 2021 (LTIP)1 | 415,079 | 511,112 | 7.3 | 8.3 |
12 July 2022 (LTIP) | 263,182 | 352,486 | 8.3 | 9.3 |
28 July 2023 (LTIP) | 1,343,091 | – | 9.3 | – |
Total | 2,313,509 | 2,574,403 | 8.0 | 6.1 |
Weighted | ||
average | ||
exercise | ||
price | Number | |
Outstanding at 01 April 2022 | € 0.00 | 3,959,643 |
Granted during the year | € 0.00 | 620,698 |
Forfeited during the year | € 0.00 | (1,570,164) |
Exercised during the year | € 0.00 | (435,774) |
Expired during the year | € 0.00 | – |
Outstanding at 31 March 2023 | € 0.00 | 2,574,403 |
Granted during the year | € 0.00 | 1,438,216 |
Forfeited during the year | € 0.00 | (1,131,001) |
Exercised during the year | € 0.00 | (568,109) |
Expired during the year | € 0.00 | – |
Outstanding at 31 March 2024 | € 0.00 | 2,313,509 |
Metric | Weighting (% of award) | Threshold | Maximum | |
Vesting (% of maximum) | 25% | 100% | ||
EBITDA per share in FY24 | 60% | €0.15 | €0.24 | |
Cumulative Sales Volume (FY22 to FY24) (m | 3 ) | 30% | 267,000 | 297,000 |
ESG – improvement in reporting ratings | 10% | 33% on attaining each of the 3 year milestones: | ||
Y1 – Attain investor ESG external rating/score | ||||
Y2 – Improve or at least maintain ESG external rating/score | ||||
Y3 – Improve or at least maintain ESG external rating/score |
Element A | Element B | Element C | |
Element | (EBITDA per share) | (Sales volume growth) | (ESG Reporting Metrics) |
Grant date | 23 Jun 21 | 23 Jun 21 | 23 Jun 21 |
Share price at grant date (€) | 2.06 | 2.06 | 2.06 |
Exercise price (€) | 0.00 | 0.00 | 0.00 |
Expected life (years) | 3 | 3 | 3 |
Contractual life (years) | 10 | 10 | 10 |
Vesting conditions (Details set out above) | EBITDA | Sales volume growth | ESG reporting metrics |
Risk free rate | -0.67% | -0.67% | -0.67% |
Expected volatility | 20% | 20% | 20% |
Expected dividend yield | 0% | 0% | 0% |
Fair value of option | € 2.06 | € 2.06 | € 2.06 |
Metric | Weighting (% of award) | Threshold | Maximum | |
Vesting (% of maximum) | 25% | 100% | ||
Cumulative Sales Volume (FY23 to FY25) (m | 3 ) | 25% | 206,000 | 232,000 |
Average Gross contribution (%) | 25% | 49.60% | 55% | |
Share performance compared to AIM Index | 40% | Median | Upper quartile | |
ESG – improvement in reporting ratings | 10% | 15% improvement in S&P | 20% improvement in S&P | |
ESG score over the three- | ESG score over the three- | |||
year period | year period |
Element B | Element D | |||
Element A | (Gross Contribution | Element C | (ESG Reporting | |
Element | (Sales volume growth) | %) | (Share price growth) | Metrics) |
Grant date | 12 Jul 22 | 12 Jul 22 | 12 Jul 22 | 12 Jul 22 |
Share price at grant date (€) | 1.21 | 1.21 | 1.21 | 1.21 |
Exercise price (€) | 0.00 | 0.00 | 0.00 | 0.00 |
Expected life (years) | 3 | 3 | 3 | 3 |
Contractual life (years) | 10 | 10 | 10 | 10 |
Vesting conditions (Details set out above) | Sales volume | Gross Contribution % | Share price | ESG reporting metrics |
Risk free rate | 0.45% | 0.45% | 0.45% | 0.45% |
Expected volatility | 20% | 20% | 20% | 20% |
Expected dividend yield | 0% | 0% | 0% | 0% |
Fair value of option | € 1.21 | € 1.21 | € 0.90 | € 1.21 |
Metric | Weighting (% of award) | Threshold | Maximum |
Vesting (% of maximum) | 25% | 100% | |
Cumulative Sales Revenue (FY24 to FY26) (€) | 45% | €500m | €600m |
Underlying EBITDA per share (€) | 45% | 0.18 | 0.20 |
6% improvement in | 9% improvement in | ||
S&P ESG score over the | S&P ESG score over the | ||
ESG – improvement in reporting ratings | 10% | three-year period | three-year period |
Element B | |||
Element A | (Underlying | Element D | |
Element | (Cumulative sales revenue) | EBITDA per share) | (ESG Reporting Metrics) |
Grant date | 28 Jul 23 | 28 Jul 23 | 28 Jul 23 |
Share price at grant date (€) | 1.24 | 1.24 | 1.24 |
Exercise price (€) | 0.00 | 0.00 | 0.00 |
Expected life (years) | 3 | 3 | 3 |
Contractual life (years) | 10 | 10 | 10 |
Vesting conditions (Details set out above) | Sales revenue | EBITDA per share | ESG reporting metrics |
Risk free rate | 2.755% | 2.755% | 2.755% |
Expected volatility | 20% | 20% | 20% |
Expected dividend yield | 0% | 0% | 0% |
Fair value of option | € 1.24 | € 1.24 | € 1.24 |
Internal | Intellectual | |||
Development | property | |||
costs | rights | Goodwill | Total | |
€’000 | €’000 | €’000 | €’000 | |
Cost | ||||
At 01 April 2022 | 7,642 | 74,992 | 4,231 | 86,865 |
Additions | 57 | 380 | – | 437 |
At 31 March 2023 | 7,699 | 75,372 | 4,231 | 87,302 |
Additions | 50 | 335 | – | 385 |
At 31 March 2024 | 7,749 | 75,707 | 4,231 | 87,687 |
Accumulated amortisation | ||||
At 01 April 2022 | 2,894 | 73,137 | – | 76,031 |
Amortisation | 385 | 395 | – | 780 |
At 31 March 2023 | 3,279 | 73,532 | – | 76,811 |
Amortisation | 399 | 429 | – | 828 |
At 31 March 2024 | 3,678 | 73,961 | – | 77,639 |
Net book value | ||||
At 31 March 2024 | 4,071 | 1,746 | 4,231 | 10,048 |
At 31 March 2023 | 4,420 | 1,840 | 4,231 | 10,491 |
At 31 March 2022 | 4,748 | 1,855 | 4,231 | 10,834 |
Land and | Plant and | Office | ||
buildings | machinery | equipment | Total | |
€’000 | €’000 | €’000 | €’000 | |
Cost or valuation | ||||
At 01 April 2022 | 17,976 | 187,445 | 4,353 | 209,774 |
Additions | – | 21,376 | 341 | 21,717 |
Foreign currency translation gain | – | – | 3 | 3 |
At 31 March 2023 | 17,976 | 208,821 | 4,697 | 231,494 |
Additions | – | 1,779 | 333 | 2,112 |
Reclassification | – | (3,669) | (451) | (4,120) |
At 31 March 2024 | 17,976 | 206,931 | 4,579 | 229,486 |
Accumulated depreciation | ||||
At 01 April 2022 | 1,353 | 29,495 | 2,265 | 33,113 |
Charge for the year | 358 | 5,397 | 572 | 6,327 |
Foreign currency translation gain | – | – | 3 | 3 |
Impairment loss | – | 86,000 | – | 86,000 |
At 31 March 2023 | 1,711 | 120,892 | 2,840 | 125,443 |
Charge for the year | 358 | 6,847 | 482 | 7,687 |
Foreign currency translation gain | – | – | 2 | 2 |
Impairment loss | – | 7,000 | – | 7,000 |
Reclassification | – | (3,669) | (451) | (4,120) |
At 31 March 2024 | 2,069 | 131,070 | 2,873 | 136,012 |
Net book value | ||||
At 31 March 2024 | 15,907 | 75,861 | 1,706 | 93,474 |
At 31 March 2023 | 16,265 | 87,929 | 1,857 | 106,051 |
At 31 March 2022 | 16,623 | 157,950 | 2,088 | 176,661 |
Right-of-use assets | ||
2024 | 2023 | |
€’000 | €’000 | |
Right-of-use assets | ||
Properties | 2,762 | 2,880 |
Equipment | 973 | 1,148 |
Motor Vehicles | 1 | 16 |
3,736 | 4,044 |
Minimum lease payments | ||
2024 | 2023 | |
€’000 | €’000 | |
Amounts payable under lease liabilities: | ||
Within one year | 771 | 1,132 |
In the second to fifth years inclusive | 2,364 | 2,085 |
After five years | 3,242 | 3,502 |
Less: future finance charges | (2,039) | (1,984) |
Present value of lease obligations | 4,338 | 4,735 |
2024 | 2023 | |
€’000 | €’000 | |
Depreciation charge of right-of-use assets | ||
Properties | 428 | 893 |
Equipment | 625 | 255 |
Motor Vehicles | 11 | 34 |
1,064 | 1,182 | |
Interest expense (included in finance cost) | 292 | 294 |
Expense relating to short-term leases (included in cost of goods sold and administrative expenses) | 22 | 60 |
Expense relating to leases of low-value assets that are not shown above as short-term leases (included in administrative expenses) | 18 | 18 |
Expense relating to variable lease payments not included in lease liabilities (included in administrative expenses) | – | – |
2024 | 2023 | |
€’000 | €’000 | |
Shares held in Cleantech Building Materials PLC | – | – |
2024 | 2023 | |
€’000 | €’000 | |
Raw materials and work in progress | 18,214 | 24,220 |
Finished goods | 7,529 | 5,726 |
25,743 | 29,946 |
2024 | 2023 | |
€’000 | €’000 | |
Trade receivables | 14,044 | 14,398 |
Other receivables | 1,616 | 1,154 |
VAT receivable | 874 | 1,472 |
Prepayments | 1,078 | 1,051 |
17,612 | 18,075 |
2024 | 2023 | |
€’000 | €’000 | |
Up to 30 days overdue | 714 | 1,361 |
Over 30 days and up to 60 days overdue | 117 | 290 |
Over 60 days and up to 90 days overdue | 17 | – |
Over 90 days overdue | – | 14 |
848 | 1,665 |
2024 | 2023 | |
€’000 | €’000 | |
Value Recovery Instrument (“VRI”) | 1,102 | 1,383 |
2024 | 2023 | |
€’000 | €’000 | |
Trade payables | 11,824 | 17,942 |
Other taxes and social security payable | 847 | 1,083 |
Accruals and deferred income | 6,126 | 6,871 |
18,797 | 25,896 |
2024 | 2023 | ||
€’000 | €’000 | ||
Allotted – Equity share capital | |||
239,518,372 | Ordinary shares of €0.05 each (2023: 219,381,693 Ordinary shares of €0.05 each) | 11,976 | 10,963 |
11,976 | 10,963 |
Capital | Hedging | ||||
redemption | Merger | Effectiveness | Total Other | ||
reserve | reserve | reserve | Other reserve | reserves | |
€000 | €000 | €000 | €000 | €000 | |
Balance at 1 April 2022 | 148 | 106,707 | 295 | 7,551 | 114,701 |
Total comprehensive income for the period | – | – | 42 | – | 42 |
Balance at 31 March 2023 | 148 | 106,707 | 337 | 7,551 | 114,743 |
Total comprehensive income for the period | – | – | – | – | – |
Balance at 31 March 2024 | 148 | 106,707 | 337 | 7,551 | 114,743 |
2024 | 2023 | |
€’000 | €’000 | |
Opening balance | 30,859 | 3,216 |
Investment in Accoya USA | 4,926 | 28,979 |
Less: Accsys proportion (60%) of Licence fee received | – | (300) |
Loss for the year | (4,100) | (1,036) |
Closing balance | 31,685 | 30,859 |
2024 | 2023 | |
€’000 | €’000 | |
Net assets of Accoya USA (USD) | 60,002 | 58,425 |
60% of net assets of Accoya USA (EUR) | 33,359 | 32,229 |
Less: Accsys proportion (60%) of Licence fee received to date | (1,500) | (1,500) |
Foreign exchange movements | (174) | 130 |
Closing balance | 31,685 | 30,859 |
2024 | 2023 | |
€’000 | €’000 | |
Operating costs | (6,653) | (1,519) |
Operating loss | (6,653) | (1,519) |
Interest payable | (179) | (207) |
Loss before taxation | (6,832) | (1,726) |
Tax expense | – | – |
Total comprehensive loss for the financial year | (6,832) | (1,726) |
Accsys proportion (60%) of US JV EBITDA | (3,724) | (700) |
Accsys proportion (60%) of US JV EBIT | (3,993) | (911) |
Accsys proportion (60%) of US JV total loss from operations | (4,100) | (1,036) |
2024 | 2023 | |
€’000 | €’000 | |
Non-current assets | ||
Property, plant and equipment | 122,662 | 69,327 |
Right of use assets | 6,919 | 6,242 |
129,581 | 75,569 | |
Current assets | ||
Inventories | 1,201 | – |
Trade and other receivables | 114 | 236 |
Cash and cash equivalents | 6,089 | 8,701 |
7,404 | 8,937 | |
Current liabilities | ||
Trade and other payables | (10,508) | (14,682) |
Obligation under lease liabilities | (491) | (455) |
Net current liabilities | (3,595) | (6,200) |
Non-current liabilities | ||
Obligation under lease liabilities | (6,635) | (5,875) |
Other long term borrowing | (63,701) | (9,781) |
(70,336) | (15,656) | |
Net assets | 55,650 | 53,713 |
2024 | 2023 | |
€’000 | €’000 | |
Cash flows from operating activities | (4,679) | (1,147) |
Cash flows from investing activities | (56,553) | (49,568) |
Cash flows from financing activities | 58,620 | 59,181 |
Net increase in cash and cash equivalents | (2,612) | 8,466 |
2024 | 2023 | |
€’000 | €’000 | |
Loan obligations | ||
Within one year | – | 9,500 |
In the second to fifth years inclusive | 32,446 | 50,288 |
In greater than five years | 27,758 | 6,132 |
Present value of loan obligations | 60,204 | 65,920 |
Amounts payable under loan agreements – undiscounted cashflows: | ||
Within one year | 1,646 | 10,312 |
In the second to fifth years inclusive | 34,294 | 52,976 |
After five years | 43,917 | 9,962 |
Less future finance charges | (19,653) | (7,330) |
Present value of loan obligations | 60,204 | 65,920 |
2024 | 2023 | |
€’000 | €’000 | |
Cash and cash equivalents | 27,427 | 26,593 |
Less: | ||
Amounts payable under loan agreements | (60,204) | (65,920) |
Amounts payable under lease liabilities (note 17) | (4,338) | (4,735) |
Net debt | (37,115) | (44,062) |
2024 | 2023 | |
€’000 | €’000 | |
Net cash from operating activities | 7,197 | 16,733 |
Investment in property, plant and equipment | (3,475) | (30,291) |
Free cashflow | 3,722 | (13,558) |
2024 | 2023 | |
€’000 | €’000 | |
Cash and cash equivalents | 27,427 | 26,593 |
Less: Cash pledged to ABN for Letter of Credit | – | (9,828) |
Adjusted Cash | 27,427 | 16,765 |
Borrowings | Leases | Sub-total | Cash | Total | |
€’000 | €’000 | €’000 | €’000 | €’000 | |
Net debt as at 31 March 2022 | (63,989) | (5,217) | (69,206) | 42,054 | (27,152) |
Cash flows | (10,000) | 940 | (9,060) | (16,984) | (26,044) |
New leases | – | (590) | (590) | – | (590) |
Foreign exchange adjustments | – | 67 | 67 | 1,523 | 1,590 |
Other changes | 8,069 | 65 | 8,134 | – | 8,134 |
Net debt as at 31 March 2023 | (65,920) | (4,735) | (70,655) | 26,593 | (44,062) |
Cash flows | 17,000 | 1,044 | 18,044 | 533 | 18,577 |
New leases | – | (757) | (757) | – | (757) |
Foreign exchange adjustments | – | 40 | 40 | 301 | 341 |
New loans | (9,901) | – | (9,901) | – | (9,901) |
Other changes | (1,383) | 70 | (1,313) | – | (1,313) |
Net debt as at 31 March 2024 | (60,204) | (4,338) | (64,542) | 27,427 | (37,115) |
At fair value | |||||
Fair value | At amortised | though profit | At fair value | ||
2024/ € ‘000 | hierarchy | cost | or loss | through OCI | Total |
Financial assets | |||||
Trade and other receivables | 15,660 | – | – | 15,660 | |
Financial asset investments | Level 2 | – | – | – | – |
Cash and cash equivalents | 27,427 | – | – | 27,427 | |
Total | 43,087 | – | – | 43,087 |
At fair value | |||||
Fair value | At amortised | though profit | At fair value | ||
2023/ € ‘000 | hierarchy | cost | or loss | through OCI | Total |
Financial assets | |||||
Trade and other receivables | 15,552 | – | – | 15,552 | |
Financial asset investments | Level 2 | – | – | – | – |
Cash and cash equivalents | 26,593 | – | – | 26,593 | |
Total | 42,145 | – | – | 42,145 |
At fair value | |||||
Fair value | At amortised | though profit | At fair value | ||
2024/ € ‘000 | hierarchy | cost | or loss | through OCI | Total |
Financial liabilities | |||||
Borrowings – loans | (60,204) | – | – | (60,204) | |
Lease liabilities | (4,338) | – | – | (4,338) | |
Trade and other payables | (11,824) | – | – | (11,824) | |
Value Recovery Instrument (“VRI”) | Level 2 | (1,102) | – | – | (1,102) |
Total | (77,468) | – | – | (77,468) |
At fair value | |||||
Fair value | At amortised | though profit | At fair value | ||
2023/ € ‘000 | hierarchy | cost | or loss | through OCI | Total |
Financial liabilities | |||||
Borrowings – loans | (65,920) | – | – | (65,920) | |
Lease liabilities | (4,735) | – | – | (4,735) | |
Trade and other payables | (17,942) | – | – | (17,942) | |
Value Recovery Instrument (“VRI”) | (1,383) | (1,383) | |||
Total | (89,980) | – | – | (89,980) |
2024 | 2023 | |
€’000 | €’000 | |
Contracted but not provided for in respect of property, plant and equipment | – | – |
2024 | 2023 | ||
Note | €’000 | €’000 | |
Non-current assets | |||
Investments in subsidiaries | 4 | 27,283 | 25,803 |
Right of use assets | – | 3 | |
Financial asset at fair value through profit or loss | 5 | – | – |
27,283 | 25,806 | ||
Current assets | |||
Debtors | 6 | 291,756 | 279,062 |
Cash at bank and in hand | 21 | 12,062 | |
291,777 | 291,124 | ||
Creditors: amounts falling due within one year | 7 | (12,916) | (22,485) |
Net current assets | 278,861 | 268,639 | |
Creditors: amounts falling due after more than one year | 8/9 | (53,529) | (50,288) |
Net assets | 252,615 | 244,157 | |
Capital and reserves | |||
Called up Share capital | 10 | 11,976 | 10,963 |
Share premium account | 262,394 | 250,717 | |
Reserve for own shares | (8) | (8) | |
Capital redemption reserve | 148 | 148 | |
Profit and loss account | (21,895) | (17,663) | |
Total shareholders’ funds | 252,615 | 244,157 |
Share | Capital | Total | ||||
Called up | premium | redemption | Profit and | Shareholders | ||
Share capital | account | Reserve | Own Shares | loss account | Funds | |
€000 | €000 | €000 | €000 | €000 | €000 | |
Balance at 31 March 2022 | 9,638 | 223,326 | 148 | (6) | (11,535) | 221,571 |
Loss for the financial year | – | – | – | – | (6,472) | (6,472) |
Share based payments | – | – | – | – | 366 | 366 |
Shares issued | 1,325 | – | – | (2) | (22) | 1,301 |
Premium on shares issued | – | 28,477 | – | – | – | 28,477 |
Share issue costs | – | (1,086) | – | – | (1,086) | |
Balance at 31 March 2023 | 10,963 | 250,717 | 148 | (8) | (17,663) | 244,157 |
Loss for the financial year | – | – | – | – | (5,712) | (5,712) |
Share based payments | – | – | – | – | 1,480 | 1,480 |
Shares issued | 1,013 | – | – | – | – | 1,013 |
Premium on shares issued | – | 12,319 | – | – | – | 12,319 |
Share issue costs | – | (642) | – | – | – | (642) |
Balance at 31 March 2024 | 11,976 | 262,394 | 148 | (8) | (21,895) | 252,615 |
€’000 | |
Cost | |
At 1 April 2022 | 21,698 |
Additions | 8,419 |
Share based payments | 366 |
At 31 March 2023 | 30,483 |
Additions | – |
Share based payments | 1,480 |
At 31 March 2024 | 31,963 |
Impairment | |
At 1 April 2022 and 1 April 2023 and 31 March 2024 | 4,680 |
Net book value | |
At 31 March 2024 | 27,283 |
At 31 March 2023 | 25,803 |
4. Investments in subsidiaries continued | |||
2024 | 2023 | ||
% shares | % shares | ||
and voting | and voting | ||
rights | rights | ||
Class | held | held | |
Subsidiary undertakings | |||
Titan Wood Technology BV (Netherlands) | Ordinary | 100 | 100 |
Titan Wood BV (Netherlands) | Ordinary | 100 | 100 |
Titan Wood Limited (UK) | Ordinary | 100 | 100 |
Titan Wood Inc (USA) | Ordinary | 100 | 100 |
Accsys (Accoya USA) Holdings LLC (USA) | Ordinary | 100 | 100 |
Accsys USA Holdings Inc (USA) | Ordinary | 100 | 100 |
Tricoya Technologies Limited (UK) | Ordinary | 100 | 100 |
Tricoya UK Limited (UK) | Ordinary | 100 | 100 |
Accoya Color UK Limited (UK) | Ordinary | 100 | 100 |
Accsys Jersey Limited (Jersey) | Ordinary | 100 | 0 |
Joint venture undertakings | |||
Accoya USA LLC (USA) | Ordinary | 60 | 60 |
Titan Wood Technology B.V. * | The provision of technical and engineering services to licensees, and the technical |
development of acetylation opportunities. | |
Titan Wood B.V. * | The manufacture and sale of Accoya acetylated wood. |
Titan Wood Limited ** | Establishing global market penetration of Accoya and Tricoya as the premium wood and wood |
elements brands respectively for external applications requiring durability, stability and | |
reliability through the licensing of the Group’s proprietary process for wood acetylation. | |
Titan Wood Inc. **** | Provision of Sales, Marketing and Technical services. |
Accsys (Accoya USA) Holdings LLC **** | Holdings company |
Accsys USA Holdings Inc **** | Holdings company |
Tricoya Technologies Limted ** | Engaged in the commercialisation of technology for the production of Tricoya Wood Elements |
around the world. | |
Tricoya UK Limited ** | The construction and operation of manufacturing plant for Tricoya wood chips as the premium |
wood elements brand for external applications requiring durability, stability and reliability. | |
Accoya Color UK Limited (UK) ** | The manufacture of colored acetylated wood. |
Accsys Jersey Limited *** | The issuing of convertible loan notes on the Group’s behalf. |
Accoya USA LLC **** | The construction and operation of a manufacturing plant for Accoya acetylated wood to serve |
the North American market. |
2024 | 2023 | |
€’000 | €’000 | |
Shares held in Cleantech Building Materials PLC | – | – |
2024 | 2023 | |
€’000 | €’000 | |
Amounts owed by Group undertakings | 291,691 | 278,443 |
Prepayments and accrued income | 65 | 619 |
291,756 | 279,062 |
2024 | 2023 | |
€’000 | €’000 | |
Trade creditors | 707 | 908 |
Amounts owed to Group undertakings | 11,677 | 11,695 |
Obligation under lease liabilities | 6 | 3 |
Short term borrowings | – | 9,500 |
VAT | 62 | – |
Accruals and deferred income | 464 | 379 |
12,916 | 22,485 |
Minimum lease payments | ||
2024 | 2023 | |
€’000 | €’000 | |
Amounts payable under lease liabilities: | ||
Within one year | 6 | 3 |
In the second to fifth years inclusive | – | – |
After five years | – | – |
Less: future finance charges | – | – |
Present value of lease obligations | 6 | 3 |
2024 | 2023 | |
€’000 | €’000 | |
Amounts payable under loan agreements: | ||
Within one year | – | 10,311 |
In the second to fifth years inclusive | 35,940 | 52,977 |
After five years | 33,370 | – |
Less future finance charges | (15,781) | (3,500) |
Present value of loan obligations | 53,529 | 59,788 |
2024 | 2023 | ||
€’000 | €’000 | ||
Allotted – Equity share capital | |||
239,518,372 | Ordinary shares of €0.05 each (2023: 219,381,693 Ordinary shares of €0.05 each) | 11,976 | 10,963 |
11,976 | 10,963 |
2024 | 2023 | |
€’000 | €’000 | |
Loss for the financial year | (5,712) | (6,472) |
Share based payments charged to subsidiaries | 1,480 | 366 |
Proceeds from issue of shares | 13,332 | 29,802 |
Share issue costs | (642) | (1,086) |
Shares issued related to Employee share plans | – | (22) |
Own shares | – | (2) |
Net increase in shareholders’ funds | 8,458 | 22,586 |
Opening shareholders’ funds | 244,157 | 221,571 |
Closing shareholders’ funds | 252,615 | 244,157 |
2024 | 2023 | |
€’000 | €’000 | |
Final Dividend €Nil (2023: €Nil) per Ordinary share proposed and paid during year relating to the previous | ||
year’s results | – | – |